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Abstract.  Profilin  is a  conserved,  widely distributed 
actin  monomer binding protein  found in eukaryotic 
cells.  Mammalian  profilin reversibly sequesters actin 
monomers in a  high affinity profilactin  complex.  In 
vitro,  the complex is dissociated  in response to treat- 
ment with the polyphosphoinositides,  phosphatidylino- 
sitol monophosphate,  and phosphatidylinositol  4,5- 
bisphosphate.  Here,  we demonstrate  the ultrastructural 
immunolocalization  of profilin  in human  leukocytes 
and platelets.  In both cell types,  a  significant  fraction 
of profilin  is found associated with  regions of cell 
membrane devoid of actin  filaments  and  other discern- 
ible structures.  After platelet activation,  the membrane 
association of profilin reversibly increases.  This  study 
represents  the first direct evidence for an  interaction 
between profilin and phospholipids  in vivo. 
p 
ROFILIN  is  a  12-15-kD  cytoplasmic  actin  monomer 
binding protein of eukaryotic cells (Carlsson et al., 
1976;  Magdolen et al.,  1988;  Reichstein and Korn, 
1979). Mammalian profilin occurs as a single isotype (Ampe 
et al.,  1988;  Kwiatkowski and Bruns,  1988) and interacts 
with actin  monomers to sequester them  from recruitment 
into actin filaments.  In vitro, the affinity of mammalian spleen 
profilin for skeletal muscle actin monomer is relatively low, 
Kd =  1-50/~M (Markey et al.,  1982; Nishida,  1985), and 
is higher for nonmuscle actin,  K~  =  10-400 nM (Larsson 
and Lindberg, 1988), whereas profilin and actin can be puri- 
fied as a high affinity,  Ko =  1-10 nM, profilactin complex 
from  cells  (Blikstad  et  al.,  1980;  Carlsson  et  al.,  1976; 
Harris and Weeds, 1978; Maim, 1984; Markey et al., 1978). 
The factor(s) responsible for the high affinity profilactin 
complex have not been identified  (Larsson  and  Lindberg, 
1988). The transient appearance of the high affinity complex 
before and/or during platelet activation (Lind et al.,  1987; 
Markey et al., 1981) suggests that some mechanism exists in- 
side cells for its rapid formation and dissociation.  Lassing 
and Lindberg (1985) have demonstrated that the high affinity 
complex can be dissociated by treatment with the polyphos- 
phoinositides,  phosphatidylinositol  monophosphate  (PIP),' 
and  phosphatidylinositol  4,5-bisphosphate  (PIP2)  in  vitro. 
More recently,  human  platelet profilin has been shown to 
bind PIP and PIP2 reconstituted into vesicles in vitro (Lass- 
ing and Lindberg,  1988; Goldschmidt-Clermont,  P., J. Bal- 
dassare,  and I". Pollard,  manuscript  submitted for publica- 
tion). These observations raise the question as to whether or 
1. Abbreviations  used in this paper: KRP, Krebs-Ringer phosphate buffer; 
PIP, phosphatidylinositol monophosphate; PIP2, phosphatidylinositol 4,5- 
biphosphate. 
not an interaction between phosphoinositides and profilin oc- 
curs in vivo and whether this interaction regulates the transi- 
tion between the high and low affinity states of the profilactin 
complex. 
PIP and PIP2 consist of an acidic, phosphorylated inositol 
side group connected to a glycerol backbone to which two 
long hydrophobic acyl chains are attached. They are, there- 
fore, likely to reside in cellular membrane compartments, 
and indeed are widely thought to be localized to the inner 
leaflet of the plasma membrane (Garrett and Redman,  1975; 
Mauco et al.,  1987). The presence of multiple distinct meta- 
bolic pools of PIP and  PIP2  in erythrocytes and  platelets 
(Billah  and  Lapetina,  1982;  King  et al.,  1987),  suggests, 
moreover,  that  some PIP and  PIP2  are  sequestered in the 
plasma (and perhaps other intracellular) membrane(s), pos- 
sibly due to binding to cytoplasmic proteins (Anderson and 
Marchesi,  1985;  Sheetz et al.,  1982). 
In support of an intracellular  interaction between profilin 
and membrane-bound PIP and PIP2, here we provide direct 
morphologic evidence for a close association of a large por- 
tion of cellular profilin with membranes in both intact human 
platelets and leukocytes. In addition,  we demonstrate a re- 
versible, transient  association between profilin and plasma 
membrane after the activation of platelets,  consistent with 
previous observations of the formation/dissociation of pro- 
filactin complexes during  platelet activation. 
Materials and Methods 
Preparation of  Anti-Profilin Antibodies 
Human platelets and spleen were obtained as discarded materials from the 
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Massachusetts General Hospital. Profilin was purified from human platelets 
using a polyproline affinity column as described (Lind et al.,  1987),  with 
a 4  M urea rinse and 7  M urea elution step gradient. Antibodies against 
profilin were raised in rabbits injected every 3-4 wk at multiple sites with 
1 ml of an emulsion of 0.25 mg/ml profilin in normal saline, using the RIBI 
adjuvant system (RIBI Immunochemical Research, Inc., Hamilton, MT). 
Antibody production was monitored by ELISA assay and the specificity of 
antibodies validated on immunoblots acording to the method of Towbin et 
al. (1979).  Human white blood cell and platelet extracts were prepared by 
lysis with 1% Triton X-100 in the presence of 2 mM diisopropylfluorophos- 
phate, and were separated by electrophoresis on 15% polyacrylamide slab 
gels (Laemmli,  1970) before electrophoretic transfer to Immobilon paper 
(Millipore Continental Water Systems, Bedford, MA). 
Anti-profilin IgG was affinity purified. 5 mg of purified human platelet 
profilin was conjugated to 3 ml CNBr-activated Sepharose beads (Pharma- 
cia Fine Chemicals St. Louis, MO). IgG was precipitated from rabbit serum 
with 45% saturated ammonium sulfate, the precipitate collected by centrifu- 
gation at 10,000 g for 10 min at 4°C, and subsequently dissolved in and dia- 
lyzed extensively against PBS, pH 7.4.  The dialysate was passed through 
the profilin-Sepharose column two times, the column was washed with 10 
vol PBS, and bound IgG dissociated with 0.05 M glycine-HCl, pH 2.3, fol- 
lowed immediately by neutralization with 0.5 M sodium phosphate buffer, 
pH 7.7, and dialysis against PBS, pH 7.4. 
Preparation of Cells 
Platelets.  Thin  sections were cut  from platelets embedded in  Lowicryl 
K4M. The preparation of these blocks has been described by us previously 
(Hartwig et al.,  1989).  Briefly,  platelets were freshly prepared from an- 
ticoagulated blood and used immediately after a 60-min 37°C incubation 
to insure a resting state.  Some cells were fixed with 1% glutaraldehyde and 
embedded while the rest of the cells were activated by the addition of 1 U 
of thrombin per milliliter for times of 15, 30, and 300 s. 90% of the cells 
treated with thrombin for 15 s were activated as judged by the formation 
of pseudopodia. Gold particles were quantitated only in activated cells dis- 
playing pseudopodia or filapodia on their surfaces. Activation was termi- 
nated by the immediate fxation of the cells with  I% glutaraldehyde in  10 
mM sodium phosphate buffer,  pH 7.0. 
Human Polymorphonuclear  Leukocytes.  Normal  human blood from 
JHH and DJK was collected into the anticoagulant acid-citrate-dextrose (8 
vol blood/2 vol). The citrated blood was mixed with 0.5 vol of 4% dextran 
and allowed to sit for 30 min at room temperature. The buffy coat was re- 
moved, added to 3 vol of 0.11 M ammonium chloride to lyse contaminating 
red blood cells, and centrifuged at 280 g  for  10  min.  The WBC  pellet 
(60-70% polymorphonuclear leukocytes) was resuspended in 0.15 M NaCI, 
washed by centrifugation and resuspended to 1%  (vol/vol) in Krebs-Ringer 
phosphate buffer (KRP) without added calcium, pH 7.4.  Cells used in the 
electron microscope were fixed for 10 min in 1% glutaraldehyde in 10 mM 
phosphate buffer,  pH 7.4,  and embedded in Lowicryl K4M. 
Preparation of Cell Sections for the 
Electron Microscope 
Labeling of Sections  with Rabbit Anti-Profilin lgG and 8-nm Gold Parti- 
cles Coated with Goat Anti-Rabbit lgG. Gold particles, 8 nm in diameter, 
were prepared with tannic acid (Slot and Geuze,  1985)  and coated with 
affinity-purified goat anti-rabbit IgG that had been absorbed with human 
lgG. Polyclonal rabbit afffinity-purified anti-human platelet profilin IgG was 
used in all immunohistochemical studies. 
To label the cell sections with gold, cut sections were placed on the sur- 
face of 10-#l drops of 10/tg/ml of anti-profilin IgG in PBS containing 1% 
BSA, pH 8.2,  (PBS-BSA) and incubated for  I  h at 25°C.  Sections were 
washed thrice by transferring them to drops of PBS/BSA for 5 min each. 
They were then transferred to  10-/.d drops of PBS-BSA containing anti- 
rabbit IgG-coated gold. After the incubation with IgG-gold, the sections 
were washed twice in PBS, thrice in distilled water,  and stained with 2% 
uranyl acetate for 7 min followed by lead citrate for 1 min. Sections were 
viewed and photographed in a JEOL  1200-EX  electron microscope at an 
accelerating voltage of 80 kV. 
Preparation of  Metal Replicas of  Membrane Fragments 
Adherence and Cleavage of Cells.  Drops of a  1%  suspension of human 
polymorphonuclear leukocytes in KRP were placed on glass coverslips 5 mm 
in diameter for 3 min. Nonadherent cells were washed off with KRP and 
the coverslips containing adherent cells were incubated for an additional 5 
min at 37°C. The bathing KRP solution was replaced with 60 mM Pipes, 
25 mM Hepes, 10 mM EGTA, 2 mM MgCI2,  and 2 ttM phallacidin, pH 
6.9 (PHEM buffer of Schliwa et al., 1981) and the exposed membrane sur- 
face of cells cleaved from their substrate-adherent basal surface by adhering 
a polylysine-coated coverslip to their apical surface and removing it. Cover- 
slips containing membrane fragments (unroofed cells) and associated cyto- 
skeletal elements were fixed with  I% glutaraldehyde-PHEM for 10 min, 
washed in PHEM buffer for 10 min, washed for 2 min in PBS containing 
I mg/ml of sodium borohydride, and then placed in PBS/BSA for 10 min 
in preparation for gold labeling. 
Labeling  of Cell Fragments  with Rabbit Anti-Profilin IgG and 8-nm 
Gold Particles Coated with Goat Anti-Rabbit IgG. Coverslips containing 
cell fragments were covered with 25/zl of 10 t~g/ml of rabbit anti-profilin 
IgG in PBS/BSA buffer and incubated for 2  h at 37°C.  They were then 
washed with three changes of PBS/BSA solution and covered with 25 ILl of 
rabbit anti-goat IgG-coated gold at a 1:10 dilution of  the stock and incubated 
for  1 h  at  37°C.  Unbound gold  was removed using five wash cycles of 
PBS/BSA followed by three washes of PBS for 5 min each. Gold labeled 
membranes were then  fixed for  10  min  at  room temperature  with  1% 
glutaraldehyde in  10 mM sodium phosphate buffer,  pH 7.0. 
Rapid-Freezing  and  Freeze-Drying.  Coverslips  containing  unroofed 
cells were washed with three changes of distilled water.  They were then 
placed on the specimen mount of the rapid-freezing apparatus (Med-Vac, 
Inc, St.  Louis, MO) and frozen by slamming them onto a liquid helium- 
cooled copper block (Hartwig and Shevlin, 1986). Freezing tabs containing 
the frozen coverslips were transferred to a liquid nitrogen-cooled stage of 
a  Cressington CFE-50  freeze fracture apparatus,  the  stage temperature 
raised to -80°C for 45 min, and then rotary coated with platinum at 25 ° 
and carbon at 90 °. Replicas were separated from the coverslip with 25% 
hydrofluoric acid, placed in bleach for 30 min, washed into distilled water, 
and then picked up on the surface of carbon-formvar-coated copper grids. 
Grids were made hydrophilic before use by glow discharge. Replicas were 
photographed at +10 ° of tilt at 100 kV in a JEOL 1200-EX electron micro- 
scope. 
Quantitation  of Gold Label on Cell Sections.  The distribution of gold 
particles was quantitated  in  different regions of platelets and  polymor- 
phonuclear leukocytes.  Gold label generally took the form of small ag- 
gregates composed of an average of four to eight particles (Table 1), although 
as  many  as 40  individual  particles could  be  found occasionally  in  ag- 
gregates. The total  number of gold particles, the number of gold in ag- 
gregates, and the total number of gold aggregates were quantitated. All gold 
particles and particle aggregates within a defined zone of  a cell were counted 
and the area of the zone determined by tracing its boundaries on the surface 
of a  digitizing pad.  Areas,  total  particles, and particles per micrometer 
squared of cytoplasm, as well as the number of gold particle aggregates as- 
sociated with a length of membrane (per micrometer) were determined as 
previously described (Hartwig et al., 1989; Hartwig and Shevlin, 1986) and 
are expressed as mean  +  the standard error of the mean per cell.  Data 
means were compared using a two-tailed, unpaired t test. 
Total gold particles and gold particle aggregates lying in three different 
intracellular zones of platelets were counted:  (a)  <10 nm of the plasma 
membrane; (b) cytoplasmic, excluding all particles determined to be plasma 
or intracellular organelle membrane associated; (c) residing on internal cell 
membranes such as intracellular dense granules,  mitochondria, and the 
platelet canalicular system. Total gold label in each of these compartments 
was determined and data expressed as percent of total gold label in a cell 
section. The percent of gold label at the membrane of polymorphonuclear 
leukocytes was also determined for comparison to membrane labeling in 
platelets. 
Results 
Specificity of  Rabbit Anti-Human Profilin Antibodies 
Fig.  1 shows an immunoblot demonstrating the specificity of 
afffinity-purified  rabbit anti-profilin IgG for human profilin. 
Shown in lanes 1-3 is a Coomassie blue-stained  15%  SDS 
polyacrylamide gel of purifed human platelet profilin,  and 
extracts  of detergent-solubilized  human white  blood cells, 
and human platelets, respectively. Lanes 4-6 show the corre- 
sponding immunoblot using the anti-profilin IgG, of an iden- 
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Location  Total  Percent total  Gold  Percent total  No.  gold per 
Activity state  in cell  gold/#m"  cellular gold  aggregates/#m  2  aggregates  aggregate 
Resting  PM  244  ±  17  16.7  +  1.6  37.5  +  2.1  13.8  +  1.3  6.5 
IM  177  ±  15  16.8  +  1.4  43.6  5-  6.1  22.6  5- 4.1  4.1 
Cytoplasm  86  +  8  66.4  5-  1.4  15.8  5-  1.8  63.6  5- 4.1  5.5 
Activated  (15  s)  PM  389  -1-  19  24.5  5-  1.0  62.2  5-  2.3  26.6  5- 0.9  6.3 
IM  194  ±  18  17.7  5-  1.8  40.0  5-  2.7  24.8  +  2.1  4.9 
Cytoplasm  129  ±  10  59.3  5-  3.1  15.9  5-  1.0  50.0  5-  2.1  8.1 
Activated (30  s)  PM  257  5-  12  19.8  ±  1.5  42.7  5-  1.9  20.4  5-  1.6  6.1 
IM  169  +  12  16.0  5-  1.1  36.9  5-  2.7  23.1  5-  2.7  4.6 
Cytoplasm  117  5-  9  64.2  5-  1.7  17.5  5-  2.0  58.5  5-  3.6  6.7 
Activated  (5  rain)  PM  262  5-  17  19.4  5-  1.2  43.5  5-  2.5  20.2  5-  1.2  6.0 
IM  141  5-  13  15.7  +  1.7  28.9  5-  2.1  21.3  5-  2.7  4.9 
Cytoplasm  99  ±  5  64.7  5-  2.1  14.4  5-  0.8  58.6  5-  2.9  6.9 
The area (p.m  2) for the membrane compartment included gold particles and/or gold aggregates contained in a zone  10 nm from the plasma membrane (plasma 
membrane length  x  10 nm). Gold labeling is expressed as percent of total  label  in all  cellular compartments. 20 platelets were analyzed to derive these data, 
which are expressed as mean ___ SEM per platelet.  Resting platelets were activated by the addition of 1 U/ml of thrombin. PM, peripheral membrane; 1114, internal 
membrane structures. 
tical set of three lanes.  In all cases, only polypeptides with 
electrophoretic mobil±ties  corresponding to  the  15,000-Mr 
profilin polypeptide bound the IgG. 
Localization of  Profilin in Resting and Activated 
Platelets: Platelet Profilin Is Associated 
with Plasma and Internal Cell Membranes 
Fig. 2 a shows a representative electron micrograph of Lowi- 
cryl-embedded resting platelets labeled with afffinity-purified 
rabbit  anti-profilin  IgG,  followed by  8-nm  gold  particles 
coated with goat anti-rabbit IgG. The discoid shape of the 
Figure 1. Specificity of anti-profilin IgG by immunoblot. Purified 
human profilin (lane 1 ) and detergent-solubilized extracts from hu- 
man leukocytes (lane 2) and platelets (lane 3) were electrophoresed 
on a 15% polyacrylamide slab gel in the presence of 0.1% SDS, and 
stained wth Coomassie  blue.  Molecular  mass standards are  in- 
cluded in the lefimost lane (LMW), with sizes in kilodaltons indi- 
cated. Replicate gel lanes, 4-6, respectively, were electrophoreti- 
cally  transferred  to Immobilon  paper,  and  incubated with  0.15 
/zg/ml of rabbit anti-profilin IgG, followed by horseradish peroxi- 
dase-conjugated goat anti-rabbit  IgG and 0.01% o-diansidine and 
H202. 
gel-filtered platelets indicates that these cells are in a resting 
state.  Anti-profilin gold label, in the form of aggregates con- 
taining an average of four to eight and occasionally as many 
as 40 gold particles (Table I), was observable in several com- 
partments of the cell. Some appeared to reside within cyto- 
plasm separate from any definable organelles. Aggregates of 
gold were also associated with plasma membrane and intra- 
cellular  membranes.  There was  no  gold  labeling  of cells 
when they were incubated with IgG-coated gold and preim- 
mune rabbit IgG (Fig.  3). 
The distribution of profilin label in the sections was quanti- 
tated by morphometry (Table I). This analysis focussed on 
the apportionment of label between plasma membrane, intra- 
cellular membranes, and cytoplasm. 16.7 +  1.6% of the total 
anti-profilin gold particles and 13.8 +  1.3% (mean -I- SEM) 
of gold aggregates were associated with the plasma  mem- 
brane in the resting platelet, whereas 16.8 +  1.4 and 22.6 + 
4.1% of total gold and gold aggregates, respectively, were as- 
sociated with membrane-bound intracellular granules or or- 
ganelles. The concentration of gold aggregates per microme- 
ter of plasma membrane was  1.7  +  0.1  (n  =  17 platelets). 
The Distribution of  Profilin in Thrombin-activated and 
Postactivated Cells: The Amount of  Profilin 
Interacting with Membrane Reversibly Increases 
during Cell Activation 
Fig. 2 b-d demonstrates the intracellular distribution of pro- 
filin in electron micrographs of thin sections of platelets that 
have been activated with 1 U/ml of thrombin for 15, 30, and 
300 s, respectively. Treatment of platelets with this concen- 
tration of thrombin resulted in an immediate (15 s) extension 
of filopodia from the cell margins (Fig. 2 b).  These exten- 
sions were more elaborate 30 s postthrombin treatment, at 
a time when intracellular granules have become compressed 
in the cell center (Fig. 2 c). After 5 min of incubation with 
thrombin,  however, the  cells returned to  a  more uniform 
morphology characterized by small,  blunt  surface protru- 
sions (Fig. 2 D). The profilin-membrane association increased 
markedly after 15 s incubation of the cells with thrombin. 
Total gold label at the plasma membrane increased to 24.5 
+  1.0% and gold in aggregates to 26.6 +  0.9% at that time, 
Hartwig et al. Reversible Association of Profilin  with Membrane  1573 Figure 2. Electron micrographs showing the distribution of anti-profilin gold staining in Lowicryl sections from resting and activated plate- 
lets. Platelets, fixed with 1% glutaraldehyde, were embedded in Lowicryl K4M, sectioned, and sequentially treated with rabbit anti-profilin 
IgG and 8-nm colloidal gold particles coated with goat anti-rabbit IgG. (a) Representative section through a resting platelet. (b) Platelet 
treated with 1 U/ml of thrombin for 15 s, and then fxed. (c) Platelet treated with thrombin for 30 s, and then fixed. (d) Platelet incubated 
with thrombin for 5 min. Bar, 0.5/zm. 
The Journal of Cell Biology, Volume 109, 1989  1574 Figure 3. Representative electron micrograph showing the complete 
lack of gold labeling in platelets treated with thrombin for 15 s, 
fixed (same as in Fig. 2 b) and incubated with 10 #g/ml of preim- 
mune rabbit IgG and 8-nm colloidal gold particles coated with goat 
anti-rabbit  IgG. Bar, 0.5/xm. 
whereas that associated with intracellular granules and the 
membranes comprising the platelet canalicular system was 
unchanged (17.7 +  1.8 and 24.8  +  2.1%  vs.  16.8 +  1.4 and 
22.6 +  4.1%  in resting cells, respectively) (Fig. 2 b and Ta- 
ble I). Conversely, anti-profilin gold particle aggregates in 
cytoplasm diminished with cell activation from 63.6 +  4.1% 
at rest to 50.0  +  2.1%  after thrombin treatment. Activated 
platelets had 2.8 +  0.1 (n =  24 platelets) gold aggregates per 
micrometer membrane 15 s after treatment with thrombin. 
These data indicate that profilin in the cytoplasm of the rest- 
ing cell rapidly moved to the plasma membrane in response 
to activation. After longer treatment with thrombin, the per- 
cent association of profilin with the membrane was found to 
decrease by comparison with 15 s of activation, but was still 
elevated relative to resting cells (Fig. 2 c and d, Table I). A 
corresponding return of gold label to cytoplasmic locations 
was  apparent  in  the  30-s  and  5-min postthrombin treated 
platelets. When preimmune IgG was substituted for the anti- 
profilin IgG,  there  was  a  complete lack  of gold  labeling 
bound to the cell sections (Fig.  3). 
Distribution of  Profilin in Human 
Polymorphonuclear Leukocytes 
The above results indicated that profilin was binding to plate- 
let plasma membranes. We next examined the distribution of 
profilin in  human  polymorphonuclear leukocytes.  Leuko- 
cytes were used both to afford a second cell type for examina- 
tion, and because it is possible to mechanically unroof  them, 
permitting a three-dimensional assessment of  profilin's mem- 
brane interaction in rapidly frozen, freeze-dried cells. 
Polymorphonuclear leukocytes labeled densely with-the 
anti-profilin IgG and gold particles. As was found in plate- 
lets, anti-profilin label occurred in aggregates composed of 
many individual gold particles (Fig. 4), and a sizeable por- 
tion of the label was associated with cellular membranes, 
both plasma and intracellular, including nuclear membrane 
(see Fig. 4 b).  1.9 +  0.1 (mean +  SEM, n  =  14 leukocytes) 
gold  particle  aggregates  were  bound  per  micrometer  of 
plasma membrane in leukocytes, similar to that found in un- 
activated platelet plasma membrane (1.7 +  0.1). We estimate 
that the plasma membrane-associated label represents ,o6.5 % 
of  the  total  anti-profilin  staining  in  these  cells.  2  Little 
anti-profilin staining was observed in the nucleus of leuko- 
cytes. 
Anti-Profilin Gold Particles Bind to the Cytoplasmic 
Side of the Plasma Membrane 
To visualize more directly the interaction of profilin with the 
membrane,  unroofed polymorphonuclear leukocytes were 
incubated with the anti-profilin IgG and anti-rabbit IgG- 
coated gold conjugate. As shown in Fig. 5, the cytoplasmic 
side of the adherent cell membrane is exposed by the unroof- 
ing procedure and this membrane surface is diffusely deco- 
rated with the gold label. Label occurred predominantly as 
single gold particles, each lying directly on the membrane, 
although individual particles tended to form loose patches 
consisting of three to six particles and covering "-,100 nm  ~ 
of membrane area. Gold particles (Fig. 5, white arrows) were 
not associated with the sides or ends of membrane-attached 
filaments or with regions of membrane decorated with clath- 
rin-coated pits. No labeling of the external side of the plasma 
membrane was observed. The gold label, therefore, repre- 
sents  binding of anti-rabbit  IgG-coated gold conjugate to 
anti-profilin IgG, which is recognizing either free profilin or 
profilin-actin complex bound to the plasma membrane. 
Discussion 
Profilin is an abundant (30-40/zM in platelets) actin mono- 
mer sequestering protein which has been found ubiquitously 
in mammalian cells (Blikstad et al.,  1980; Carlsson et al., 
1976;  Kwiatkowski and Bruns,  1988). Based upon in vitro 
studies  of its interaction with PIP2 in micelles and mixed 
vesicles (Lassing and Lindberg,  1985,  1988;  Goldschmidt- 
Clermont, P., J. Baldassare, and T. Pollard, manuscript sub- 
mitted for publication), it has been proposed that intracellu- 
lar PIP2 regulates the profilin-actin bond in a  physiologi- 
cally important manner. Here, we provide the first studies of 
the immunolocalization of profilin in mammalian cells, and 
are able to demonstrate directly that profilin is found in close 
association with both the internal leaflet of the plasma mem- 
brane and external surfaces of intracellular membranes in 
human platelets and leukocytes. As profilin is known to bind 
with high affinity only to actin monomers and phosphoinosi- 
tides, the observed membrane localization is likely to reflect 
its direct binding to PIP and PIP2 inside the cell. 
2. This calculation  assumes that polymorphonuclear leukocytes have 10 ~m 
diameters. 
Hartwig et al.  Reversible Association of Profilin  with Membrane  1575 Figure 4. Electron micrographs showing anti-profilin  staining in a polymorphonuclear  leukocyte. (a) Clusters of anti-profilin  label densely 
stain the peripheral  cytoplasm and the plasma membrane at many points.  Gold label is also seen on intracellular membranes. (b) Gold 
labeled the external side of mitochondria, intmcellular  granules, and the nuclear membrane. Few gold particles are seen in the nucleoplasm. 
Bar, 0.5/~m. 
The Journal of Cell Biology, Volume 109, 1989  1576 Figure 5. Electron micrograph showing the distribution of anti-profilin  gold label on the cytoplasmic side of an unroofed polymorphonuclear 
leukocyte. Cells, adherent to glass, were unroofed by adhering and removing polylysine-coated coverslips. This representative electron 
micrograph shows that profilin is found on regions of membrane free of actin filaments and coated pits, and not on the remaining actin 
filaments adjacent to the membrane at the cell edges. Gold particles are indicated by the white arrows. Bar, 0.1  #m. 
Hartwig et al. Reversible Association of Profilin with Membrane  1577 Platelet activation with thrombin  is  well-recognized to 
cause a marked shape change reaction, accompanied by actin 
polymerization and alterations in levels of the high affinity 
profilactin complex.  Although the precise  time course of 
events as assessed by different investigators have been some- 
what variable (Lind et al.,  1987; Markey et al.,  1981), all 
agree that early on (0-10 s) during platelet activation, there 
are high levels of the profilactin complex as well as  un- 
polymerized actin, while later (30 s-5 min) profilin is found 
free or in a low affinity complex with actin, and extensive 
actin polymerization occurs. In our experiments, activation 
of platelets with thrombin resulted in a rapid and reversible 
movement of anti-profilin gold label to the plasma mem- 
brane  (Fig.  3).  Maximal movement to the membrane oc- 
curred temporally just before the onset of actin polymeriza- 
tion (Lind et al.,  1987).  These observations are consistent 
with the hypothesis that the high affinity profilactin complex 
in platelets must interact with phosphoinositides resident in 
the plasma membrane to yield free profilin and actin for actin 
assembly (Lassing and Lindberg, 1985, 1988).  The subse- 
quent decreased amount of gold label found at the membrane 
after longer periods of thrombin treatment, may indicate the 
transient nature of the profilin phosphoinositide interaction, 
due either to hydrolysis of PIP2 to inositol  1,4,5  trisphos- 
phate and diacylglycerol by phospholipase C, or other mech- 
anisms. Indeed, as intracellular Ca  2÷ release,  mediated by 
inositol 1,4,5 trisphosphate, is thought to increase the affinity 
of phospholipase C for PIP2 (Manne and Kung, 1987),  this 
event would provide a  mechanism for dissociating profilin 
from the membrane. Because of  the coordinated, finely regu- 
lated and spatially circumscribed nature of most cell move- 
ments, similar morphologic evidence for a transient mem- 
brane interaction with profilin will be difficult or impossible 
to obtain in other cell types. Nonetheless, as a general mech- 
anism, uncoupling of actin from profilin at the membrane, 
in conjunction with generation of actin nuclei or the uncap- 
ping of filament ends, would link receptor stimulation and 
actin filament growth both temporally and spatially. 
These observations also lend further support to the con- 
cept that profilin may serve an important physiologic role in 
the  regulation  of  polyphosphoinositide  metabolism.  We 
found that 13.8% and 22.6% of anti-profilin gold label was 
associated with plasma and internal membranes of resting 
platelets, respectively. If the profilin concentration in plate- 
lets is 30-40/~M (Goldschmidt-Clermont, P., J. Baldassare, 
and T. Pollard, manuscript submitted for publication) then 
11  I~M  profilin  is  membrane associated.  The  binding  of 
profilin  to  PIP  and  PIP:  in  the  membrane  may  occur 
through a single profilin-PIP2 bond or possibly through in- 
teraction with several (up to eight) inositide head groups, as 
recently proposed  (Goldschmidt-Clermont, P.,  J.  Baldas- 
sare, and T. Pollard, manuscript submitted for publication). 
Clustering of acidic phospholipids has been noted in mixed 
vesicle preparations in vitro (Eklund et al., 1988; Haverstick 
and Glaser, 1987), and may well occur in vivo. Thus, profilin 
could bind  11-88 ttM PIP and PIP2 in platelets, where the 
PIP and PIP2 concentrations are estimated to be  100-200 
/zM (Rittenhouse and Sasson,  1985).  Evidence for distinct 
metabolic pools of phosphoinositides has been obtained in 
both red blood cells (King et al., 1987) and platelets (Billah 
and  Lapetina,  1982).  Short-term  labeling experiments  in 
thrombin-stimulated platelets have also suggested that nearly 
all  the  PIP2 turnover  occurs  at  the  plasma  membrane 
(Mauco et al.,  1987). 
These latter observations are consistent with the possible 
sequestration of  polyphosphoinositides by cellular components. 
Glycophorin (Anderson and Marchesi,  1985)  and gelsolin 
(Janmey and Stossel,  1989) are other PIP2 binding proteins 
that may participate in this process. Our current results pro- 
vide further evidence for the importance of phospholipid- 
protein interactions, and suggest that the profilin-phospho- 
inositide interaction may have wide consequence in control 
of phosphoinositide metabolism and cell signalling. 
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